Skip to main content

Table 2 Differences in bacterial microbiota according to T-RFLP analysis

From: The gut microbiota composition in patients with right- and left-sided colorectal cancer and after curative colectomy, as analyzed by 16S rRNA gene amplicon sequencing

 

Control (n = 10)

RCC (n = 10)

SCC (n = 6)

RCR (n = 9)

SCR (n = 6)

Bifidobacterium

6.54 ± 6.75

5.06 ± 7.14

8.18 ± 10.83

9.23 ± 7.96

15.7 ± 12.15

Lactobacillales

0.94 ± 0.88

9.76 ± 8.56*

6.70 ± 9.02

8.78 ± 10.85*

3.72 ± 2.88*

Bacteroides

49.7 ± 10.6

37.5 ± 18.9

52.5 ± 23.1

50.1 ± 11.2

47.4 ± 17.3

Prevotella

5.19 ± 9.92

7.93 ± 14.1

7.98 ± 14.9

1.19 ± 2.87

0.12 ± 0.29

Clostridium IV

5.87 ± 6.85

12.1 ± 9.3**

3.2 ± 3.17

2.97 ± 2.49**

4.7 ± 2.05

Clostridium XIVa

15.7 ± 4.14

15.7 ± 6.97

11.4 ± 3.37*,**

15.6 ± 7.5

17.5 ± 4.14**

Clostridium IX

8.54 ± 8.1

1.33 ± 2.13*

2.6 ± 3.19

3.96 ± 8.3

2.25 ± 2.81

Clostridium XI

0.19 ± 0.41

0.73 ± 1.3

0.23 ± 0.48

0.18 ± 0.53

1.25 ± 1.49*

Clostridium XVIII

1.98 ± 1.8

2.27 ± 2.76

1.35 ± 1.02

1.22 ± 0.96

1.33 ± 1.44

Other

5.42 ± 2.74

7.57 ± 3.56

5.88 ± 4.75

6.79 ± 4.96

6.0 ± 3.15

  1. P-values are based on the Kruskal–Wallis test; the data are expressed as the means ± SDs; T-RFLP, terminal restriction fragment length polymorphism. *P < 0.05 vs. the control; **Significant difference between the preoperative and postoperative groups (P < 0.05)
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us